DE2845745C2 - - Google Patents

Info

Publication number
DE2845745C2
DE2845745C2 DE2845745A DE2845745A DE2845745C2 DE 2845745 C2 DE2845745 C2 DE 2845745C2 DE 2845745 A DE2845745 A DE 2845745A DE 2845745 A DE2845745 A DE 2845745A DE 2845745 C2 DE2845745 C2 DE 2845745C2
Authority
DE
Germany
Prior art keywords
prp
pertussis
phosphate buffer
isolation
sodium phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2845745A
Other languages
German (de)
English (en)
Other versions
DE2845745A1 (de
Inventor
Joseph S.-C. Orangeburg N.Y. Us Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/846,466 external-priority patent/US4196192A/en
Priority claimed from US05/846,488 external-priority patent/US4220717A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE2845745A1 publication Critical patent/DE2845745A1/de
Application granted granted Critical
Publication of DE2845745C2 publication Critical patent/DE2845745C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19782845745 1977-10-28 1978-10-20 Kombinationsvaccine Granted DE2845745A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (2)

Publication Number Publication Date
DE2845745A1 DE2845745A1 (de) 1979-05-10
DE2845745C2 true DE2845745C2 (zh) 1987-10-01

Family

ID=27126641

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782845745 Granted DE2845745A1 (de) 1977-10-28 1978-10-20 Kombinationsvaccine

Country Status (25)

Country Link
JP (1) JPS5480408A (zh)
AR (1) AR218932A1 (zh)
AU (1) AU520902B2 (zh)
BE (1) BE871586A (zh)
CA (1) CA1117866A (zh)
CH (1) CH649781A5 (zh)
DD (1) DD140701A5 (zh)
DE (1) DE2845745A1 (zh)
DK (1) DK154327C (zh)
ES (1) ES474611A1 (zh)
FI (1) FI63674C (zh)
FR (1) FR2407000B1 (zh)
GB (1) GB2007244B (zh)
GR (1) GR73991B (zh)
HU (1) HU178166B (zh)
IE (1) IE47474B1 (zh)
IL (1) IL55433A (zh)
IT (1) IT1107570B (zh)
NL (1) NL7810753A (zh)
NO (1) NO149611C (zh)
NZ (1) NZ188211A (zh)
PH (1) PH15882A (zh)
PL (1) PL210545A1 (zh)
SE (1) SE430753B (zh)
YU (1) YU250878A (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate
DE69113564T2 (de) * 1990-08-13 1996-05-30 American Cyanamid Co Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
WO1993004183A1 (en) * 1991-08-16 1993-03-04 Merck & Co., Inc. Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
NO116869B (zh) * 1965-01-19 1969-06-02 Merck & Co Inc
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
NL174267B (nl) * 1969-05-20 Roussel Uclaf Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
FR2253499B1 (zh) * 1973-12-10 1977-11-04 Fabre Sa Pierre
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Also Published As

Publication number Publication date
DK154327C (da) 1989-04-03
HU178166B (en) 1982-03-28
BE871586A (fr) 1979-04-27
CH649781A5 (de) 1985-06-14
DE2845745A1 (de) 1979-05-10
FI63674C (fi) 1983-08-10
NO149611B (no) 1984-02-13
SE430753B (sv) 1983-12-12
SE7811192L (sv) 1979-04-29
GB2007244B (en) 1982-03-31
FI783269A (fi) 1979-04-29
GR73991B (zh) 1984-06-06
PL210545A1 (zh) 1980-02-25
NZ188211A (en) 1984-09-28
GB2007244A (en) 1979-05-16
YU250878A (en) 1983-12-31
IE782146L (en) 1979-04-28
ES474611A1 (es) 1980-01-16
CA1117866A (en) 1982-02-09
FR2407000B1 (zh) 1983-01-21
AR218932A1 (es) 1980-07-15
DD140701A5 (de) 1980-03-26
AU4108178A (en) 1980-05-01
NO149611C (no) 1984-05-23
DK154327B (da) 1988-11-07
FR2407000A1 (zh) 1979-05-25
PH15882A (en) 1983-04-13
IT1107570B (it) 1985-11-25
DK479578A (da) 1979-04-29
JPS6231694B2 (zh) 1987-07-09
JPS5480408A (en) 1979-06-27
NL7810753A (nl) 1979-05-02
IL55433A0 (en) 1978-10-31
IT7851621A0 (it) 1978-10-24
NO783635L (no) 1979-05-02
IE47474B1 (en) 1984-03-21
FI63674B (fi) 1983-04-29
IL55433A (en) 1982-09-30
AU520902B2 (en) 1982-03-04

Similar Documents

Publication Publication Date Title
US4220717A (en) Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
DE69736709T2 (de) Vielwertige dtp-polio-impfstoffe
US4196192A (en) Combined Haemophilus influenzae type b and pertussis vaccine
DE69124235T3 (de) Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins
EP0220387B1 (de) Konjugatimpfstoffe gegen Infektionen durch gramnegative Bakterien, Verfahren zu deren Herstellung sowie Verwendung derselben
DE69232969T2 (de) Methode zur herstellung von gram-negativen bakteriellen vakzinen
EP0173241B1 (de) Vakzine zur Behandlung der Harnwegsinfektionen
EP0041897B1 (en) Polysaccharide antigen from streptococcus and vaccines
DE2024586C3 (zh)
EP0363835B1 (de) Verwendung von Zink- oder Eisenhydroxid zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen
EP0407037A1 (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
DE3024282A1 (de) Vakzinierende glycopeptid-antigenfraktion mit grosser immunisierungsfaehigkeit, isoliert aus kulturen pathogener keime, verfahren zur isolierung dieser fraktion und diese enthaltende vakzinen
EP0201796B1 (de) Treponema hyodysenteriae-Bacterin und Verfahren für dieses
DE2845745C2 (zh)
DE2833545A1 (de) Hochmolekulare meningokokken- gruppe c-vaccine und verfahren zu ihrer herstellung
DD202623A5 (de) Verfahren zur herstellung von sporen-polyosiden
DE3152621C2 (zh)
DE3541044A1 (de) Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt
US4203970A (en) Swine atropic rhinitis vaccine
US3075883A (en) Novel parenteral vaccine antigen compositions and methods of making and using
DE69329922T3 (de) Herstellung eines tetanusimpfstoffes
US5045456A (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
DE2737060C2 (de) Escherichia coli-Neurotoxin
DE3740182C2 (de) Verfahren zur Herstellung eines Mutantenstamms von Bordetella bronchiseptica, der für einen Impfstoff für den Schutz von B. bronchiseptica-Infektionen nützlich ist, und daraus hergestellter AR-Impfstoff
DE10115276A1 (de) Impfstoff zum Schutze von Geflügel gegen Salmonellose und ein Verfahren zur Herstellung desselben

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee